Ventas, Inc. Prepares for Q4 Earnings Report Amid Strong Analyst Support
Ventas, Inc. (VTR), based in Chicago, Illinois, stands out in the real estate investment trust (REIT) sector by focusing on communities for an aging population. Currently valued at $24.7 billion, the company manages various properties including senior housing, skilled nursing facilities, hospitals, and medical offices across the U.S. and Canada. Investors are closely watching as the leading healthcare REIT is set to release its fiscal fourth-quarter earnings for 2024 after market closure on Wednesday, February 12.
Projected Earnings and Previous Performance
Analysts predict VTR will report funds from operations (FFO) of $0.80 per share on a diluted basis, marking a 5.3% increase from $0.76 per share in the same quarter last year. The company has consistently met or exceeded Wall Street’s FFO estimates over the last four quarters.
Full-Year Outlook and Growth Expectations
For the entire fiscal year, analysts anticipate VTR’s FFO to reach $3.16, up 5.7% from $2.99 for fiscal 2023. Additionally, FFO is expected to grow by 7.3% year over year, reaching approximately $3.39 in fiscal 2025.
Stock Performance Compared to Market Trends
Over the past year, VTR stock has seen a 22.7% increase, which falls short of the S&P 500’s ($SPX) impressive 26.5% rise during the same period. Nevertheless, VTR has outperformed the Real Estate Select Sector SPDR Fund’s (XLRE) 6.5% growth.
Recent Results and Market Sentiment
On October 30, VTR shares experienced a slight uptick following its Q3 earnings report. The company’s FFO matched analyst expectations at $0.80, while revenue reached $1.24 billion, exceeding Wall Street’s projections of $1.21 billion. Looking ahead, VTR estimates full-year FFO between $3.14 and $3.18.
Analyst Recommendations and Price Outlook
The consensus among analysts regarding VTR stock is quite positive, earning a “Strong Buy” rating overall. Out of 19 analysts, 13 recommend a “Strong Buy,” two suggest a “Moderate Buy,” and four advise a “Hold.” The average analyst price target stands at $70.50, hinting at a potential upside of 19.7% from current trading levels.
On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are solely for informational purposes. For more information, please view the Barchart Disclosure Policy here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
